Skip to main content
Top
Published in: Journal of Assisted Reproduction and Genetics 11/2019

01-11-2019 | Miscarriage | Genetics

Defining the role of FMR1 gene in unexplained recurrent spontaneous abortion

Authors: Deepika Delsa Dean, Sarita Agarwal, Srinivasan Muthuswamy

Published in: Journal of Assisted Reproduction and Genetics | Issue 11/2019

Login to get access

Abstract

Introduction

Recurrent spontaneous abortion is a multifactorial disorder and till date, various factors have been attributed in its pathogenesis. Still, approximately 50% of RSA cases remain unexplained. Premutation (PM) expanded allele of fragile-X mental retardation 1 (FMR1) gene is known to contribute to ovarian dysfunction in 20% of the cases. Recently, the link between expanded FMR1 allele and recurrent miscarriages has been reported.

Method

In the present prospective case–control study, we have investigated the status of CGG repeat size at 5′UTR of the FMR1 gene in women with unexplained RSA in comparison to age-matched healthy control women (n = 100 each). The genomic DNA from these samples was subjected to molecular analysis for characterization of CGG repeat size and composition at FMR1 gene

Results

As compared to the control women, the RSA women cohort had a higher frequency of carriers with alleles in gray zone (GZ) and expanded PM range, i.e., 2% (2/100) versus 5% (5/100), respectively. Also, the RSA cohort had a significantly higher number of normal alleles with ≥ 35 CGG repeats (24 out of 200 alleles) as compared to control cohort (8 out of 200 alleles). The number of larger FMR1 alleles with pure CGG repeat tract was found to be significantly higher (P = 0.0063) in the RSA cohort (15 out of 200 alleles) as compared to that in control cohort (3 out of 200 alleles).

Conclusion

Henceforth, the CGG expanded uninterrupted FMR1 allele might be associated with recurrent abortions and may help to explain many of these unexplained cases.
Literature
2.
go back to reference Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Green-top Guideline No. 17. Royal College of Obstetricians and Gynaecologists (RCOG), 2011. Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Green-top Guideline No. 17. Royal College of Obstetricians and Gynaecologists (RCOG), 2011.
3.
go back to reference Practice Committee of the American Society for Reproductive Medicine, 2012Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012; 98: 1103–1111 Practice Committee of the American Society for Reproductive Medicine, 2012Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012; 98: 1103–1111
4.
go back to reference Ali O, Hakimi I, Chanana A, et al. Grossesse sur utérus cloisonné menée à terme: à propos d’un cas avec revue de la literature. The Pan African Medical Journal. 2015;22:219.PubMedPubMedCentral Ali O, Hakimi I, Chanana A, et al. Grossesse sur utérus cloisonné menée à terme: à propos d’un cas avec revue de la literature. The Pan African Medical Journal. 2015;22:219.PubMedPubMedCentral
5.
go back to reference Cohn DM, Goddijn M, Middeldorp S, et al. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost. 2010;8:2208–13.PubMedCrossRef Cohn DM, Goddijn M, Middeldorp S, et al. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost. 2010;8:2208–13.PubMedCrossRef
6.
go back to reference Srinivas SK, Ma Y, Sammel MD, Chou D, et al. Placental inflammation and viral infection are implicated in second trimester pregnancy loss. Am J Obstet Gynecol. 2006;195:797–802.PubMedCrossRef Srinivas SK, Ma Y, Sammel MD, Chou D, et al. Placental inflammation and viral infection are implicated in second trimester pregnancy loss. Am J Obstet Gynecol. 2006;195:797–802.PubMedCrossRef
7.
go back to reference Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med. 2006;24:33–9.PubMedCrossRef Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med. 2006;24:33–9.PubMedCrossRef
8.
go back to reference Pluchino N, Drakopoulos P, Wenger JM, Petignat P, et al. Hormonal causes of recurrent pregnancy loss (RPL). Hormones (Athens). 2014;13(3):314–22.CrossRef Pluchino N, Drakopoulos P, Wenger JM, Petignat P, et al. Hormonal causes of recurrent pregnancy loss (RPL). Hormones (Athens). 2014;13(3):314–22.CrossRef
9.
10.
go back to reference Dubey S, Chowdhury MR, Prahlad B, Kumar V, Mathur R, et al. Cytogenetic causes for recurrent spontaneous abortions – an experience of 742 couples (1484 cases). Indian J Hum Genet. 2005;11:94–8.CrossRef Dubey S, Chowdhury MR, Prahlad B, Kumar V, Mathur R, et al. Cytogenetic causes for recurrent spontaneous abortions – an experience of 742 couples (1484 cases). Indian J Hum Genet. 2005;11:94–8.CrossRef
11.
go back to reference Iravathy GK, Raina V, Verma S, Chadha G. Cytogenetics and genetic counselling of patients in North India. J K Science. 2006;8:28–30. Iravathy GK, Raina V, Verma S, Chadha G. Cytogenetics and genetic counselling of patients in North India. J K Science. 2006;8:28–30.
12.
go back to reference Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996;66(1):24–9.PubMedCrossRef Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996;66(1):24–9.PubMedCrossRef
13.
go back to reference Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007;50(1):132–45.PubMedCrossRef Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007;50(1):132–45.PubMedCrossRef
14.
go back to reference Toth B, Jeschke U, Rogenhofer N, Scholz C, Wurfel W, Thaler CJ, et al. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010;85(1):25–32 Epub 2010/02/27.PubMedCrossRef Toth B, Jeschke U, Rogenhofer N, Scholz C, Wurfel W, Thaler CJ, et al. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010;85(1):25–32 Epub 2010/02/27.PubMedCrossRef
15.
go back to reference Daher S, Mattar R, Gueuvoghlanian-Silva BY, Torloni MR. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol. 2012;67(4):341–7.PubMedCrossRef Daher S, Mattar R, Gueuvoghlanian-Silva BY, Torloni MR. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol. 2012;67(4):341–7.PubMedCrossRef
17.
go back to reference Sullivan AK, Marcus M, Epstein MP, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20(2):402–12.PubMedCrossRef Sullivan AK, Marcus M, Epstein MP, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20(2):402–12.PubMedCrossRef
18.
go back to reference Pastore LM, Young SL, Baker VL, Karns LB, Williams CD. Silverman LM Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012 Nov;19(11):1226–31.PubMedPubMedCentralCrossRef Pastore LM, Young SL, Baker VL, Karns LB, Williams CD. Silverman LM Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012 Nov;19(11):1226–31.PubMedPubMedCentralCrossRef
19.
go back to reference Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril. 2009;92(2):464–70.PubMedCrossRef Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril. 2009;92(2):464–70.PubMedCrossRef
20.
go back to reference Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril. 2009;91(5):1700–6.PubMedCrossRef Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril. 2009;91(5):1700–6.PubMedCrossRef
21.
go back to reference Karimov CB, Moragianni VA, Cronister A, Srouji S, Petrozza J, Racowsky C, et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod. 2011;26(8):2077–83.PubMedCrossRef Karimov CB, Moragianni VA, Cronister A, Srouji S, Petrozza J, Racowsky C, et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod. 2011;26(8):2077–83.PubMedCrossRef
22.
go back to reference Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011;29:299–307.PubMedCrossRef Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011;29:299–307.PubMedCrossRef
23.
go back to reference Man L, Lekovich J, Rosenwaks Z, Gerhardt J. Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations. Front Mol Neurosci. 2017;10:290.PubMedPubMedCentralCrossRef Man L, Lekovich J, Rosenwaks Z, Gerhardt J. Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations. Front Mol Neurosci. 2017;10:290.PubMedPubMedCentralCrossRef
24.
go back to reference Murray A, Webb J, MacSwiney F, Shipley EL, Morton NE, Conway GS. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod. 1999;14:1217–8.PubMedCrossRef Murray A, Webb J, MacSwiney F, Shipley EL, Morton NE, Conway GS. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod. 1999;14:1217–8.PubMedCrossRef
25.
go back to reference Rohr J, Allen EG, Charen K, Giles J, He W, Dominguez C, et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod. 2008;23:1220–5.PubMedCrossRef Rohr J, Allen EG, Charen K, Giles J, He W, Dominguez C, et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod. 2008;23:1220–5.PubMedCrossRef
26.
go back to reference Harper PS, Jones L. Huntington's disease: genetic and molecular studies. In: Harper PS, Jones L, editors. Huntington’s disease, edited by Bates GP. Oxford, UK: Oxford University Press; 2002. p. 113–58. Harper PS, Jones L. Huntington's disease: genetic and molecular studies. In: Harper PS, Jones L, editors. Huntington’s disease, edited by Bates GP. Oxford, UK: Oxford University Press; 2002. p. 113–58.
27.
go back to reference Dean DD, Agarwal S, Tripathi P. Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages. J Assist Reprod Genet. 2018;35(12):2121–8.PubMedPubMedCentralCrossRef Dean DD, Agarwal S, Tripathi P. Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages. J Assist Reprod Genet. 2018;35(12):2121–8.PubMedPubMedCentralCrossRef
28.
go back to reference Bodega B, Bione S, Dalprà L, Toniolo D, Ornaghi F, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2005;21(4):952–7.PubMedCrossRef Bodega B, Bione S, Dalprà L, Toniolo D, Ornaghi F, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2005;21(4):952–7.PubMedCrossRef
29.
go back to reference Lekovich J, Man L, Xu K, Canon C, Lilienthal D, et al. CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve. Genet Med. 2018;20(9):957–64.PubMedCrossRef Lekovich J, Man L, Xu K, Canon C, Lilienthal D, et al. CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve. Genet Med. 2018;20(9):957–64.PubMedCrossRef
30.
go back to reference Srinivasan M, Dean DD, Agarwal S. Molecular screening of intellectually disabled and premature ovarian failure cases for CGG repeat expansion at FMR1 locus: implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis. Neurol India. 2016;64(6):1175–9.CrossRef Srinivasan M, Dean DD, Agarwal S. Molecular screening of intellectually disabled and premature ovarian failure cases for CGG repeat expansion at FMR1 locus: implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis. Neurol India. 2016;64(6):1175–9.CrossRef
31.
go back to reference Bibi G, Malcov M, Yuval Y, Reches A, Ben-Yosef D, et al. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis. Fertil Steril. 2010;94(3):869–74.PubMedCrossRef Bibi G, Malcov M, Yuval Y, Reches A, Ben-Yosef D, et al. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis. Fertil Steril. 2010;94(3):869–74.PubMedCrossRef
32.
go back to reference Pastore LM, Christianson MS, McGuinness B, Vaught KC, et al. Does theFMR1 gene affect IVF success? Reprod BioMed Online. 2019;38(4):560–9.PubMedCrossRef Pastore LM, Christianson MS, McGuinness B, Vaught KC, et al. Does theFMR1 gene affect IVF success? Reprod BioMed Online. 2019;38(4):560–9.PubMedCrossRef
33.
go back to reference Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005;117:376–82.PubMedCrossRef Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005;117:376–82.PubMedCrossRef
34.
go back to reference Bodega B, Bione S, Dalpr’a L, Toniolo D, Ornaghi F, Vegetti W, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2006;21:952–7.PubMedCrossRef Bodega B, Bione S, Dalpr’a L, Toniolo D, Ornaghi F, Vegetti W, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2006;21:952–7.PubMedCrossRef
35.
36.
go back to reference Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–54.CrossRef Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–54.CrossRef
37.
go back to reference Watson MS, Breg WR, Pauls D, Brown WT, Carroll AJ, Howard-Peebles PN, et al. Aneuploidy and the fragile X syndrome. Am J Med Genet. 1988;30(1-2):115–21.PubMedCrossRef Watson MS, Breg WR, Pauls D, Brown WT, Carroll AJ, Howard-Peebles PN, et al. Aneuploidy and the fragile X syndrome. Am J Med Genet. 1988;30(1-2):115–21.PubMedCrossRef
38.
go back to reference Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet. 2000;8:247–52.PubMedCrossRef Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet. 2000;8:247–52.PubMedCrossRef
39.
go back to reference Hundscheid RD, Smits AP, Thomas CM, Kiemeney LA, Braat DD. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure. Am J Med Genet A. 2003;117A:6–9.PubMedCrossRef Hundscheid RD, Smits AP, Thomas CM, Kiemeney LA, Braat DD. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure. Am J Med Genet A. 2003;117A:6–9.PubMedCrossRef
40.
go back to reference Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22:2142–52.PubMedCrossRef Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22:2142–52.PubMedCrossRef
41.
go back to reference Trout SW, Seifer DB. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertil Steril, 2000, vol. 74 (pg. 335-337)PubMedCrossRef Trout SW, Seifer DB. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertil Steril, 2000, vol. 74 (pg. 335-337)PubMedCrossRef
42.
go back to reference Gurbuz B, Yalti S, Ozden S, Ficicioglu C. High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Arch Gynecol Obstet. 2004;270:37–9.PubMedCrossRef Gurbuz B, Yalti S, Ozden S, Ficicioglu C. High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Arch Gynecol Obstet. 2004;270:37–9.PubMedCrossRef
43.
go back to reference Dean DD, Agarwal S, Kapoor D, Vati C. Molecular characterization of FMR1 gene in reproductive age women and premature ovarian insufficiency cases by TP-PCR. J mol Diagn Ther. 2017;22:91–100.CrossRef Dean DD, Agarwal S, Kapoor D, Vati C. Molecular characterization of FMR1 gene in reproductive age women and premature ovarian insufficiency cases by TP-PCR. J mol Diagn Ther. 2017;22:91–100.CrossRef
44.
go back to reference Chatterjee S, Maitra A, Kadam S, et al. CGG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure. Reprod BioMed Online. 2009;19(2):281–6.PubMedCrossRef Chatterjee S, Maitra A, Kadam S, et al. CGG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure. Reprod BioMed Online. 2009;19(2):281–6.PubMedCrossRef
45.
go back to reference Kline J, Kinney A, Brown S, Levin B, Oppenheimer K, Warburton D. Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus. Hum Reprod. 2012;27(7):2224–32.PubMedCrossRefPubMedCentral Kline J, Kinney A, Brown S, Levin B, Oppenheimer K, Warburton D. Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus. Hum Reprod. 2012;27(7):2224–32.PubMedCrossRefPubMedCentral
Metadata
Title
Defining the role of FMR1 gene in unexplained recurrent spontaneous abortion
Authors
Deepika Delsa Dean
Sarita Agarwal
Srinivasan Muthuswamy
Publication date
01-11-2019
Publisher
Springer US
Keyword
Miscarriage
Published in
Journal of Assisted Reproduction and Genetics / Issue 11/2019
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-019-01591-x

Other articles of this Issue 11/2019

Journal of Assisted Reproduction and Genetics 11/2019 Go to the issue